Carzenide

CAS No. 138-41-0

Carzenide( —— )

Catalog No. M11595 CAS No. 138-41-0

Carzenide is an organic synthesis intermediate, for synthetic drug.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 29 In Stock

Biological Information

  • Product Name
    Carzenide
  • Note
    Research use only, not for human use.
  • Brief Description
    Carzenide is an organic synthesis intermediate, for synthetic drug.
  • Description
    Carzenide is an organic synthesis intermediate, for synthetic drug.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    138-41-0
  • Formula Weight
    201.2
  • Molecular Formula
    C7H7NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    NS(=O)(=O)C1=CC=C(C=C1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Petzinger E. Dtsch Tierarztl Wochenschr. 1992 Oct;99(10):412-5.
molnova catalog
related products
  • Pseudo RACK1

    Activator of protein kinase C; attached to cell permeabilization Antennapedia domain vector peptide. Consists of peptide derived from the C2 domain of PKC β linked by a disulfide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the activator peptide. Once inside the cell, the disulfide bonds are subjected to reduction in the cytoplasm leading to release of the activator peptide.

  • Ricinine

    Ricinine is a major alkaloid in Ricinus communis plant with hepatoprotection in CCl4 -induced liver damage.

  • GSK2807 Trifluoroace...

    GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM).GSK2807, a potent and selective, SAM-competitive inhibitor of SMYD3 (Ki = 14 nM).?A high-resolution crystal structure reveals that GSK2807 bridges the gap between the SAM-binding pocket and the substrate lysine tunnel of SMYD3.